These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2169780)

  • 21. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
    Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W
    J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation.
    Spitzer TR; Friedman CJ; Bushnell W; Frankel SR; Raschko J
    Bone Marrow Transplant; 2000 Jul; 26(2):203-10. PubMed ID: 10918432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation.
    Abbott B; Ippoliti C; Bruton J; Neumann J; Whaley R; Champlin R
    Bone Marrow Transplant; 1999 Feb; 23(3):265-9. PubMed ID: 10084258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Oral granisetron solution as prophylaxis for chemotherapy-induced emesis in children: double-blind study of 2 doses].
    Mabro M; Cohn R; Zanesco L; Madon E; Hahlen K; Margueritte G; Breatnach F; Gentet JC; Plouvier é
    Bull Cancer; 2000 Mar; 87(3):259-64. PubMed ID: 10779814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High versus low dose granisetron, a selective 5HT3 antagonist, for the prevention of chemotherapy-induced nausea and vomiting.
    Falkson HC; Falkson CI; Falkson G
    Invest New Drugs; 1990 Nov; 8(4):407-9. PubMed ID: 1964678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of granisetron in the prevention of chemotherapy-induced emesis in paediatric patients.
    Lemerle J; Amaral D; Southall DP; Upward J; Murdoch RD
    Eur J Cancer; 1991; 27(9):1081-3. PubMed ID: 1659848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
    Slabý J; Trnený M; Procházka B; Klener P
    Neoplasma; 2000; 47(5):319-22. PubMed ID: 11130251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of prophylactic intravenous granisetron in postoperative emesis in adults.
    Hanaoka K; Toyooka H; Kugimiya T; Ohashi Y;
    J Anesth; 2004; 18(3):158-65. PubMed ID: 15290412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy.
    Jones E; Koyama T; Ho RH; Kuttesch J; Shankar S; Whitlock JA; Cartwright J; Frangoul H
    Pediatr Blood Cancer; 2007 Mar; 48(3):330-2. PubMed ID: 16304666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repeated use of granisetron in patients receiving cytostatic agents.
    de Wet M; Falkson G; Rapoport BL
    Cancer; 1993 Jun; 71(12):4043-9. PubMed ID: 8389659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized controlled study comparing two doses of intravenous granisetron (1 and 3 mg) for acute chemotherapy-induced nausea and vomiting in cancer patients: a non-inferiority trial.
    Yonemura M; Katsumata N; Hashimoto H; Satake S; Kaneko M; Kobayashi Y; Takashima A; Kato Y; Takeuchi M; Fujiwara Y; Yamamoto H; Hojo T
    Jpn J Clin Oncol; 2009 Jul; 39(7):443-8. PubMed ID: 19395466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Granisetron, a antiemetic for treatment of cytostatic drug-induced vomiting: results of a practice-oriented study].
    Golaszewski T; Kölbl H; Lahousen M; Staab HJ
    Wien Klin Wochenschr; 1995; 107(20):613-21. PubMed ID: 7502509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Granisetron: is there a dose-response effect on nausea and vomiting?
    Minami M
    Cancer Chemother Pharmacol; 2003 Aug; 52(2):89-98. PubMed ID: 12783208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of granisetron as a single agent with conventional combination antiemetic therapies in the treatment of cytostatic-induced emesis. The Granisetron Study Group.
    Marty M
    Eur J Cancer; 1992; 28A Suppl 1():S12-6. PubMed ID: 1320913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial.
    Walsh T; Morris AK; Holle LM; Callander N; Bradshaw P; Valley AW; Clark G; Freytes CO
    Bone Marrow Transplant; 2004 Dec; 34(11):963-8. PubMed ID: 15489869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical evaluation of granisetron for nausea and vomiting induced by anticancer drugs--multi-centered placebo-controlled double-blind comparative study].
    Suminaga M; Furue H; Ohta K; Taguchi T; Niitani H; Ogawa N
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1211-9. PubMed ID: 8392826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose granisetron remain effective over multiple cycles? The Granisetron Study Group.
    Blijham GH
    Eur J Cancer; 1992; 28A Suppl 1():S17-21. PubMed ID: 1320914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral granisetron--simple and effective: a preliminary report. The Granisetron Study Group.
    Hacking A
    Eur J Cancer; 1992; 28A Suppl 1():S28-32. PubMed ID: 1320917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous granisetron--establishing the optimal dose. The Granisetron Study Group.
    Kamanabrou D
    Eur J Cancer; 1992; 28A Suppl 1():S6-11. PubMed ID: 1320919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.